LRRK2 and Parkinson disease: From examining the number of participants with PD that viewed their 23andMe genetic health risk reports, 46% were aware of their LRRK2 p.G2019S and GBA1 p.N409S carrier status, and 32% were aware of their APOE E4 carrier status.